Dr. Wen Chen
Professor and DeanFudan University, China
Highest Degree
Ph.D. in Social Medicine and Health Administration from Shanghai Medical University, China
Share this Profile
Biography
Dr. Wen Chen is curently working as Professor of Health Economics and Dean, School of Public Health, Fudan University, China. He obtained his PhD in Social Medicine and Health Administration from Shanghai Medical University in 1998. He also worked on number of research projects as Principal Investigator and Co-Investigator. He is the author and co-author of more than 100 journal papers, and 14 conference posts. He also gives more than 8 oral presentations.
Area of Interest:
Selected Publications
- Yip ,W., T.Powell-Jackson,W.Chen,M.Hu,E,Fe et al 2014. Capitation combined with pay-for-performance improves antibiotic prescribing practices in rural China. Health Aff., 33: 502-510.
CrossRef | PubMed | Direct Link | - Kennedy-Martin, T., B. D. Mitchell, K.S. Boye, W. Chen, B. H. Curtis et al, 2014. The health technology assessment environment in mainland china, japan, southkorea, and taiwan—implications for the evaluation of diabetes mellitus therapies. Value Health Reg.issue, 3: 108-116.
CrossRef | Direct Link | - Chen, M., L. Wang, W. Chen, L. Zhang, H. Jiang and W. Mao, 2014. Does economic incentive matter for rational use of medicine? China's experience from the essential medicines program. PharmacoEconomics, 32: 245-255.
CrossRef | Direct Link | - C. Daniel Mullins, C. O.Nneka,G.T. B.de Afaujo, W. Chen, J. X. Ales Tichopadet al, 2014. Guidance document: global pharmacoeconomic model adaption strategies. Value Health Reg.issue, 5: 7-13.
CrossRef | Direct Link | - ZHANG, L., W. Lijie, C.Wen, M. Wenhui, J. Hongli, and F. Wenjun., 2013. Pharmaceutical utilization behaviors and cognition of medical professionals with the implementation of the essential medicines policies Chinese Health Resour., 16: 98-100.
Direct Link | - Wenhui, M., Z. Luying, C. Wen, C.Mingsheng and J.Hongli 2013. Allocation and utilization of essential medicines at primary health care institutions. Chinese Health Res., 16: 95-97.
Direct Link | - Mao.W,S.Tang andW.Chen, 2013. Does perverse economic incentive lead to the irrational uses of medicines? Expert Rev Pharmacoecon Outcomes Res., 13: 693-696.
CrossRef | PubMed | Direct Link | - Jingjing, Z., F. Wenjun, H.G. Yunyu, and C. Wen., 2013. Economic burden of type 2 diabetes mellitus with nephropathy complications in China. Chinese Health Econom., 32: 32-34.
Direct Link | - Wenhui, M.,L. Hua, C.Wen and J. Hongli 2012. Introduction of Australian drug pricing system and its revelation to Chinese drug regulation. BMC Health Serv Res., 15: 427-430.
- Chi-Man, Y.W., C.H. William, C. Wen, H. Shanlian, M. Jin and M. Alan, 2012. Early appraisal of China's huge and complex health-care reforms. Lancet, 379: : 833-842.
CrossRef | Direct Link | - Yip, W.C.M., W. Hsiao, Q. Meng, W. Chen and X. Sun, 2010. Realignment of incentives for health-care providers in China. Lancet, 375: 1120-1130.
CrossRef | - WANG L.,C. Wen, 2010.. Comparison of governmental compensation methods for essential health care delivery in public hospitals. Chinese Health Resources 13: 255-257.
Direct Link | - Wen C.,H.Jinlin 2009. Pharmacoeconomic evaluation of telbivudine vs. lamivudine in treating the patients with HBeAg-positive and negative chronic hepatitis B, Chin J Hepatol, 17: 569-573.
Direct Link | - Yanyan M., W.Chen,H. Jianget al 2007. Analysis on medical expenditure containment related policy (2): Basic medical insurance policy. Chinese Health Resources 10: : 139-141.
- Chen.,W.Chen,H. Jiang, 2007. Analysis on medical expenditure containment related policy (3): policy on drug expenditure containment. Chinese Health Resou., 10: 175-177.
Direct Link | - Kangning B., Y.Gu, Wen Chenet al 2006. Cost-effectiveness analysis of oral vs. intravenous iron treatment for renal anemia patients. Chin J. Nephrol, 22: 596-600.
Direct Link | - Kangning B., W.Chen and S.Hu 2005. Systematic evaluation of pharmacoeconomic literatures on domestic digestive system diseases. China Pharmacy 16: 278-280.
Direct Link | - Wen C.,X.Ying and X.Lu., 2004. Organizing and financing urban employees`supplementary medical insurance Chin J Hosp Admin., 20: 648-653.
Direct Link | - Chen W., H. Shanlian and Y.Xiaohua 2000. Cost-utility analysis of cefepime vs ceftazidime in treatment of patients with medium or severe pneumonia. J.Clinical Pharmac., 9: 237-241.
Direct Link |